The adverse effects with ibuprofen after major orthopedic surgeries: A protocol for the PERISAFE randomized clinical trial
Authors:
- 30 January 2025
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 69 (3) , e14578
Abstract
Introduction: Non‐steroidal anti‐inflammatory drugs (NSAIDs) are recommended for pain treatment after elective hip and knee arthroplasties. However, evidence regarding the incidence of adverse effects with short‐term NSAID treatment following surgery is limited. We, therefore, aim to assess the adverse effects with an eight‐day postoperative treatment with ibuprofen after elective hip and knee arthroplasties.Methods and Analysis: PERISAFE is a randomized, placebo‐controlled, blinded multicenter trial with 90‐day and one‐year follow‐up. Eligible patients undergoing elective hip or knee arthroplasty are allocated 1:1 to either ibuprofen 400 mg ×3/day or identical placebo ×3/day for eight days after surgery. The primary outcome is a composite of either death, acute myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, renal failure, major bleeding, re‐operation, gastrointestinal ulcer, or readmission within 90 days postoperatively. Secondary outcomes are hospital‐free days within 90 days postoperatively, a composite of ibuprofen and opioid‐related adverse reactions based on eight‐day postoperative diary, and health related quality of life after 90 days postoperatively.A total of 2904 patients are needed to demonstrate a relative risk reduction of 33% in the placebo group, accepting a risk of type I error of 5% and type II error of 20% and a proportion of serious adverse events in the ibuprofen group of 8%. The primary analysis will be in the modified intention‐to‐treat population.Ethics and Dissemination: The trial is approved by the Danish Medicine Agency and the Research Ethics Committee (EU CT no. 2022‐502, 502‐32‐00). We plan to submit for publication in a major international peer‐reviewed journal and present results at scientific meetings.Keywords
Funding Information
- Skibsreder Per Henriksen, R. og hustrus fond
This publication has 43 references indexed in Scilit:
- Effect of Combination of Paracetamol (Acetaminophen) and Ibuprofen vs Either Alone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip ArthroplastyJAMA, 2019
- Increase in Total Joint Arthroplasty Projected from 2014 to 2046 in Australia: A Conservative Local Model With International ImplicationsClinical Orthopaedics and Related Research, 2017
- Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and TechniquesJAMA Surgery, 2017
- Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy After Myocardial InfarctionJAMA, 2015
- Subjective and objective outcomes in randomized clinical trials: definitions differed in methods publications and were often absent from trial reportsJournal of Clinical Epidemiology, 2014
- Individual NSAIDs and Upper Gastrointestinal ComplicationsDrug Safety, 2012
- Ninety-day Mortality in Patients Undergoing Elective Total Hip or Total Knee ArthroplastyThe Journal of Arthroplasty, 2012
- Treatment of acute postoperative painThe Lancet, 2011
- The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million peoplePharmacoepidemiology and Drug Safety, 2008
- Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugsThe American Journal of Medicine, 2001